Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rice and Honey Powder (DHA Coffee Co., Ltd) is a dietary supplement composed of organic rice (92-93%) and honey (7-8%). Developed by DHA Coffee Co., Ltd, the product is formulated as a powder intended to be dissolved in hot water for oral consumption. It has been investigated in a safety study (NCT04395482) for the treatment of COVID-19, HIV infection, and various malignant neoplasms. The developer's rationale for the treatment involves the protection of telomere chromosomes and the maintenance of deoxyribonucleic acid (DNA) molecules, although these mechanisms are not clinically validated for these ingredients in the context of the specified diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rice and Honey Powder (DHA Coffee Co., Ltd).